Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 26 entries
View as:
COld Exposure With Controlled BReathing And Meditation in Patients With Multiple Sclerosis (COBRAMS)
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 09/30/20
Due: 09/30/21
Phase: N/A
Priority: Normal
Start: 02/15/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 03/30/23
Due: 03/30/24
Phase: N/A
Priority: Normal
Start: 10/01/17
End: 05/30/19
Due: 05/30/20
Phase: N/A
Priority: Normal
Start: 09/28/23
End: 03/28/24
Due: 03/28/25
Phase: N/A
Priority: Normal
Start: 06/16/17
End: 02/14/18
Due: 02/14/19
Phase: N/A
Priority: Normal
Start: 03/15/24
End: 03/15/29
Due: 03/15/30
Phase: N/A
Priority: Normal
Start: 05/01/20
End: 12/18/20
Due: 12/18/21
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 03/30/23
Due: 03/30/24
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 02/01/19
End: 03/10/20
Due: 03/10/21
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 09/01/21
Due: 09/01/22
Phase: N/A
Priority: Normal
Start: 05/01/21
End: 01/01/22
Due: 01/01/23
Phase: N/A
Priority: Normal
Start: 10/01/22
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 12/15/23
Due: 12/15/24
Phase: N/A
Priority: Normal
Start: 05/25/25
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 04/01/21
End: 08/01/22
Due: 08/01/23
Phase: N/A
Priority: Normal
Start: 02/15/24
End: 02/15/29
Due: 02/15/30
Phase: N/A
Priority: Normal
Start: 01/11/21
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 02/01/24
End: 03/30/25
Due: 03/30/26
Phase: N/A
Priority: Normal
Start: 05/15/23
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 01/31/22
Due: 01/31/23